English High Court Agrees With Teva In Asthma Treatment Lawsuit

September 4, 2014 | The English High Court ruled in support of Israeli company Teva Pharmaceutical Industries in their case against Astra-Zeneca, a multi-national pharmaceutical and biologics company. According to the court, Astra-Zeneca will not be allowed to change their patent for the smart indication of Symbicort in order to facilitate Teva’s upcoming European launch of is asthma treatment DuoResp Spiromax, using Teva’s Spiromax technology.